Please assess the completion status of the following clinical trial:

Trial Title: Drug-Drug Interaction Study Between Colchicine and Cyclosporine

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adults 18-45 years of age, non-smoking and non-pregnant (post-menopausal, surgically sterile or using effective contraceptive measures) with a body mass index (BMI) greater than or equal to 18 and less than or equal to 32, inclusive.~Exclusion Criteria:~* Recent participation (within 28 days) in other research studies~* Recent significant blood donation or plasma donation~* Pregnant or lactating~* Test positive at screening for human immunodeficiency virus (HIV), hepatitis B surface antigen (HbsAg), or hepatitis C virus (HCV)~* Recent (2-year) history or evidence of alcoholism or drug abuse~* History or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease~* Subjects who have used any drugs or substances known to inhibit or induce cytochrome (CYP) P450 enzymes and/or P-glycoprotein (P-gp) within 28 days prior to the first dose and throughout the study~* Drug allergies to colchicine or cyclosporine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Colchicine alone (Type: ACTIVE_COMPARATOR): -baseline colchicine pharmacokinetics
- Colchicine with Cyclosporine (Type: EXPERIMENTAL): -colchicine pharmacokinetics in presence of cyclosporine

Based on this trial design, predict the completion outcome and termination type (if applicable).